Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA)

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 17, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

March 31, 2026

Conditions

Myopic Chorioretinal Atrophy

Interventions

PROCEDURE

Pars plana vitrectomy

One sheet of PAL-222 is implanted into the subretinal space of either of eyes through pars plana vitrectomy.

Trial Locations (1)

Nagoya city university hospital, Nagoya